Insulin resistance, hypertension and nephropathy
1Third Department of Medicine, Shiga University of Medical Science, Seta, Ohtsu, Japan.
Summary
Insulin resistance is linked to hypertension and kidney disease progression in non-diabetic patients with type 2 diabetes. Lower insulin sensitivity predicts hypertension development and proteinuria in these individuals.
Area of Science:
- Endocrinology
- Nephrology
- Cardiovascular Medicine
Background:
- Insulin resistance is implicated in essential hypertension in non-diabetic individuals.
- Limited research exists on the link between insulin resistance, hypertension, and nephropathy in diabetes mellitus.
Purpose of the Study:
- To investigate the association between insulin resistance, hypertension development, and nephropathy progression over 7 years in non-obese, normotensive patients with non-insulin-dependent diabetes mellitus (NIDDM).
Main Methods:
- Prospective observation of 28 NIDDM patients (age >40, fasting glucose <140 mg/dl) over 7 years.
- Insulin sensitivity assessed via glucose-clamp or glucose, insulin, and somatostatin infusion.
- Monitoring of blood pressure and proteinuria.
Main Results:
- 12 of 28 patients developed hypertension; 16 remained normotensive.
- Insulin-induced glucose clearance was significantly lower in hypertensive subjects (30 ± 12 ml/kg/10 min) compared to normotensive subjects (50 ± 19 ml/kg/10 min).
- Proteinuria incidence was significantly higher in hypertensive patients (7/12) than normotensive patients (1/16; p < 0.05).
Conclusions:
- Insulin resistance is a key factor in the etiology of hypertension among NIDDM patients.
- Insulin resistance plays a significant role in the progression of diabetic nephropathy.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


